Related Experiment Video
Updated: Oct 15, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Developing Non-Laboratory Cardiovascular Risk Assessment Charts and Validating Laboratory and Non-Laboratory-Based
Razieh Hassannejad1, Marjan Mansourian2,3, Hamidreza Marateb4
1Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, IR.
A new simplified cardiovascular disease (CVD) risk assessment model uses non-laboratory factors, proving as accurate as traditional lab-based methods. This offers a valuable tool for resource-limited settings.
Area of Science:
- Cardiology
- Public Health
- Epidemiology
Background:
- Developing simplified cardiovascular disease (CVD) risk assessment models is crucial, especially in resource-limited regions.
- Existing laboratory-based models can be inaccessible due to cost and availability constraints.
Purpose of the Study:
- To develop and validate a simplified, non-laboratory CVD risk assessment chart.
- To compare the performance of the non-laboratory model against a traditional laboratory-based model.
Main Methods:
- A 10-year non-laboratory CVD risk prediction chart was developed using Cox Proportional Hazard regression on data from the Isfahan Cohort Study (ICS).
- Internal validation and external validation using the Tehran Lipid and Glucose Study (TLGS) data were performed for both non-laboratory and laboratory models.
Main Results:
- The non-laboratory model demonstrated good discrimination (Harrell's C: 0.73) and calibration (Nam-D'Agostino χ²: 11.01, p=0.27).
- It classified high-risk and low-risk patients as accurately as the laboratory-based model.
- External validation showed comparable performance for both models (Harrell's C: 0.77 for non-laboratory, 0.78 for laboratory).
Conclusions:
- A simplified, non-laboratory risk assessment model for cardiovascular disease is effective and accurate.
- This model provides a practical alternative where laboratory testing is not feasible.
- The approach enhances cardiovascular risk assessment accessibility in diverse populations.
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Pre-Procedural Guidelines for Assessing Blood Pressure
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Data Validation
Nursing assessment guides are generally based on holistic models rather than medical...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

